Searchable abstracts of presentations at key conferences in endocrinology

ea0011p493 | Endocrine tumours and neoplasia | ECE2006

Carney’s complex with acromegaly as the leading clinical condition

Fatti LM , Bertola G , Balza G , Lavezzi E , Pecori Giraldi F , Cavagnini F

Carney’s complex was first identified as the association of primary adrenal nodular dysplasia, lentigines and cardiac and skin myxomas. Several other endocrine and non-endocrine disorders were subsequently added to the complex, including pituitary tumors and melanotic Schwannomas. We herewith describe a kindred with Carney’s complex featuring acromegaly as the common denominator.Patients & methods: A 42-year-old woman first presented to our...

ea0012oc18 | Pituitary, ovary and steroids | SFE2006

Adult onset diabetes insipidus due to congenital midline defects of the brain

Zachariah S , Hyer S

A 30 year old gentleman presented with long standing symptoms of polyuria and polydypsia and poor libido. On examination he was short (155 cm), weighed 108 kg with a body mass index of 45.1. Investigations revealed normal Blood Glucose, renal function, liver function and calcium. Water deprivation test confirmed the diagnosis of Cranial Diabetes Insipidus. He was started on DDAVP tablets 100 microgram’s twice daily. Further tests showed a normal IGF-1, synacthen test and ...

ea0037ep251 | Calcium and Vitamin D metabolism | ECE2015

Low bone mass in Sheehan's syndrome: prevalence and management

Chihaoui Melika , Salah Dhouha Ben , Yazidi Meriem , Chaker Fatma , Ftouhi Bochra , Slimane Hedia

Introduction: Hypopituitarism is a known cause of bone mineral loss. Our study aimed to evaluate the frequency of osteopenia and osteoporosis in patients with Sheehan’s syndrome and to evaluate its management.Subjects and methods: It is a retrospective longitudinal study concerning 60 cases of Sheehan’s syndrome that have had a bone mineral density measurement. The parameters of osteodensitometry, the received treatment and the follow up data w...

ea0070ep539 | Hot topics (including COVID-19) | ECE2020

Seizure and coma secondary to Conn’s syndrome: A case report

Alseddeeqi Eiman

Background: Conn’s syndrome is a curable condition if identified properly. It is characterized by autonomous secretion of aldosterone from the adrenal gland cortex. Its morbidity is related to the increased risk of cardiovascular diseases.Case presentation: We report the case of a 48 years old male presenting with generalized tonic-clonic seizure and coma secondary to hypertensive encephalopathy. The biochemical evaluation revealed a very high aldo...

ea0073aep72 | Adrenal and Cardiovascular Endocrinology | ECE2021

Metabolic impact of glucocorticoid substitution in Addison’s disease

Safi Wajdi , Salah Dhoha Ben , Elmoctar Sidina Mohamed , Mohamed Abdallahi Mohamed Ahmed , Charfi Nadia , Mnif Fatma , Rekik Nabila , Mnif Mouna , Kacem Faten Hadj , Abid Mohamed

IntroductionRecent studies in patients with Addison’s disease have shown that this condition, even if treated, is fraught with significant morbidity and even excess mortality. The objective of our study was to determine the deleterious effects of long-term glucocorticoid replacement mainly on the metabolic level.MethodsRetrospective study, carried out at the Endocrinology and Diabetology Department of H&...

ea0063p1119 | Reproductive Endocrinology 2 | ECE2019

The role of omentin in inflammation and metabolic syndrome risk assessment in women with PCO-S

Zieleń-Zynek Iwona , Kowalska Joanna , Justyna Nowak , Zubelewicz-Szkodzińska Barbara

Introduction: Omentin is a visceral fat tissue adipokine which regulates metabolism (insulin sensitivity) and presents an anti-inflammatory activities, by lowering C-reactive protein concentration, in obesity and diabetes mellitus type 2. Polycystic ovary syndrome is the most common endocrinopathy in women of childbearing age. One of the major disorders in the PCOS metabolic phenotype is obesity and hyperinsulinaemia. The anthropometric indicators are useful tools for carbohyd...

ea0004p57 | Endocrine tumours and neoplasia | SFE2002

MUTATIONS IN THE SDHB GENE CAUSE INCREASED SUSCEPTIBILITY TO FAMILIAL PHAEOCHROMOCYTOMA AND PARAGANGLIOMA: A CASE REPORT

Razvi S , Wright M , Weaver J

Introduction:The genetics of most cases of familial phaechromocytomas is unknown.Up to 50%of paragangliomas arefamilial and increased susceptibility is seen in SDHD and SDHC mutations.We report a family with a mutation in the SDHB gene .Case report: The index case, a 22 year old male was treated at the age of 10 years with extra adrenal phaeochromocytoma. Recently, he was found to have ...

ea0070aep937 | Thyroid | ECE2020

Hashimoto’s thyroiditis in a patient with IgG4 related disease

Husnina Matali Nur , Lin Chong Pui

Introduction: Immunoglobulin G4 related disease (IgG4-RD) is an immune-mediated fibro-inflammatory condition and is a widely recognised multi-organ system disease. The prevalence of IgG4-RD is 6/100 000, but it is likely to be underestimated. IgG4-RD is characterised by elevated serum levels of IgG4 and IgG4-positive lymphoplasmacytic infiltrative lesions in the body. Recent reports suggest disease involvement in various organs including thyroid and orbital tissues. Thyroid di...

ea0077p151 | Adrenal and Cardiovascular | SFEBES2021

Iatrogenic Cushing’s syndrome due to betamethasone nasal drops

Alameri Majid , Alnuaimi Abdulla , Patel Kalpesh , Meeran Karim , Wernig Florian

Introduction: Iatrogenic Cushing’s syndrome (ICS) can be caused by virtually all forms of steroid treatment with or without suppression of hypothalamic–pituitary–adrenal (HPA) axis. Here we report betamethasone nasal drops used as treatment post septorhinoplasty as a cause of iatrogenic Cushing’s syndrome.Case: A 36 years old female with background history of depression presented to endocrinology clinic for evaluation of progressive w...

ea0077p100 | Neuroendocrinology and Pituitary | SFEBES2021

Conservative management of Cushing’s in COVID times: A case series and meta-analysis

Sharma Bhavna , Rahman Mushtaqar

We present a case series of patients admitted to our hospital with various manifestations of Cushing’s. 71 male, known type 2 diabetes, hypertension referred for adrenal incidentaloma. Cushingoid features with non suppressed ACTH. Low dose dexamethasone test (LDSST): no suppression. 4 cm pituitary microadenoma (likely co-secretory as gonadotropins elevated). Offered IPSS and pituitary surgery. Declined the same due to fears of COVID opted for medical therapy with metyrapo...